Mar. 20 at 9:08 PM
$SGMO ** Biotech’s Rebuffed Multi-Billion Dollar Deals **
Interesting comment about M&A from LLY Business Development lead, Jacob Van Naarden:
Jake, himself, is seeing approx 10 deals per week, ie deals that are important enough, or diligenced enough, to cross his desk.
Courtesy @adamfeuerstein on X
“What’s interesting is how many of the multi-billion dollar deals we are attempting to do, and sort of get rebuffed with some frequency.”
“We engage with a lot of publicly traded companies... and those are the ones where I’m particularly surprised you put sort of a market premium offer on the table, and you’re not even granted a conversation, so to speak, as you have a conversation, but it sort of doesn’t go anywhere.”
https://x.com/adamfeuerstein/status/2035071283117895973?s=46
